MacDougall J R, Matrisian L M
Department of Cell Biology, Vanderbilt University, Nashville, Tennessee 37232-2175, USA.
Cancer Metastasis Rev. 1995 Dec;14(4):351-62. doi: 10.1007/BF00690603.
The malignant progression of tumors is driven by the expression of oncogenes and loss of expression of tumor suppressor genes; factors that are intrinsic to cancer cells. The phenotypic changes brought about by the gain or loss of expression of oncogenes and tumor suppressor genes lead to the acquisition of malignant traits, namely, the ability to invade into and grow in ectopic tissue environments. Recently, however, focus in cancer research has widened from the cancer cell to include the surrounding tumor stroma as an integral player in the process of tumor progression. One of the areas in cancer research contributing to this enhanced appreciation of stromal involvement in tumor progression and metastasis is that of matrix metalloproteinases (MMPs). This review provides an overview of the characteristics of MMPs and discusses their role in the progression and metastasis of tumors. Initially, attention will focus on the regulation of MMPs in tumor cells but will switch to discourse on stromal expression of MMPs in tumors and speculation on the functional consequences of stromal expression of MMPs.
肿瘤的恶性进展是由癌基因的表达和肿瘤抑制基因表达的丧失驱动的,这些都是癌细胞内在的因素。癌基因和肿瘤抑制基因表达的增减所带来的表型变化导致了恶性特征的获得,即侵入异位组织环境并在其中生长的能力。然而,最近癌症研究的重点已从癌细胞扩展到包括周围肿瘤基质,将其视为肿瘤进展过程中的一个重要参与者。癌症研究中有助于增强对基质参与肿瘤进展和转移认识的领域之一是基质金属蛋白酶(MMPs)。本综述概述了MMPs的特征,并讨论了它们在肿瘤进展和转移中的作用。最初,注意力将集中在肿瘤细胞中MMPs的调节上,但随后将转向讨论肿瘤中MMPs的基质表达以及对MMPs基质表达功能后果的推测。